"chromophobe RCC (ChRCC), 5–7% of all RCCs with classic and eosinophilic variants; the mRNA expression signature overlaps with the distal nephron, (ccRCC proximal nephron):"
"advanced WHO/ISUP grade, AJCC pTNM stage"
"papillary renal cell cancer (PRCC) is the 2nd most common type of RCC:"
"the previous type 2 group includes previously unrecognized tumour types such as fumarate hydratase (FH)-deficient RCC and microphthalmia-associated transcription factor (MITF) family translocation RCC"
"the previous type 2 group includes previously unrecognized tumour types such as fumarate hydratase (FH)-deficient RCC and microphthalmia-associated transcription factor (MITF) family translocation RCC"
"FH-deficient RCC, MITF family translocation family RCC"
"FH-deficient RCC, MITF family translocation family RCC"
"acquired cystic disease-associated RCC"
"clear cell papillary RCC"
"chromophobe RCC (ChRCC), 5–7% of all RCCs with classic and eosinophilic variants; the mRNA expression signature overlaps with the distal nephron, (ccRCC proximal nephron):"
"Xp11 translocation RCC:"
"MITF rearranged RCC: two case reports only"
"PTEN hamartoma syndrome (breast, thyroid and other tumours)"
"TSC 1 and 2"
"fumarate hydratase deficient RCC, autosomal dominant and aggressive"
"SDH (A, B, C orD) deficient RCC, autosomal dominant:"
"gastric gastrointestinal stromal tumour (SDH deficient GIST)"
"Warthin-like - sometimes aggressive"
"Xp11 translocation RCC:"
"MITF family translocation RCCs may occur in childhood, but are not inherited:"
"Xp11 translocation RCC:"
"TFEB-rearranged renal cell carcinoma:"
"MITF rearranged RCC: two case reports only"
"express BRAF mutations in over 90%"
"SDH mutation (SDH deficient gastrointestinal stromal tumour (GIST), paraganglioma/phaeochromocytoma)"
"SDH (A, B, C orD) deficient RCC, autosomal dominant:"
"chromophobe RCC (ChRCC), 5–7% of all RCCs with classic and eosinophilic variants; the mRNA expression signature overlaps with the distal nephron, (ccRCC proximal nephron):"
"advanced stage, necrosis and sarcomatoid change predict aggressive behaviour and early metastases"
"solitary, sporadic and low risk of metastases"
"must be differentiated from urothelial carcinoma, metastasis and high grade mucinous tubular and spindle cell carcinomas"
"PTEN hamartoma syndrome (breast, thyroid and other tumours)"
"low grade oncocytic tumour (LOT), a recently described oncocytoma-eosinophilic tumour with fewer nuclear abnormalities"